Skip to main content
. 2026 Oct 8;15(19):1784. doi: 10.3390/biology15191784
AE/AEs Auger Electron/Auger Electrons
AI Artificial Intelligence
ALP Alkaline Phosphatase
BFC Bifunctional Chelator
BP Bisphosphonate
BPAMD Bisphosphonate derivative/DOTA-bisphosphonate derivative
CE Conversion Electron
CT Computed Tomography
DOTA 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid
DOTAM 1,4,7,10-tetrakis(carbamoylmethyl)-1,4,7,10-tetraazacyclododecane
DOTATATE DOTATOC DOTANOC DOTA-conjugated somatostatin analogs
DOTAZOL DOTA-conjugated zoledronate derivative
DOTMP 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid)
DMSA Dimercaptosuccinic acid
DTPA Diethylene triamine pentaacetic acid
DTMP Diethylenetriamine tetramethylene phosphonic acid
EC Electron Capture
EDTMP Ethylenediamine tetramethylenephosphonic acid
EGF Epidermal Growth Factor
EGFR Epidermal Growth Factor Receptor
EMA European Medicines Agency
FAPI Fibroblast Activation Protein Inhibitor
FDA Food and Drug Administration
FDG Fluorodeoxyglucose
FGFs Fibroblast Growth Factors
HDP/HMDP Hydroxymethylene diphosphonate
HEDP Hydroxyethylidene diphosphonate
HEDTA N-hydroxyethylene diamine triacetic acid
HYNIC Hydrazinonicotinamide
IBA Ibandronate
IGFs Insulin-like Growth Factors
IL-6 Interleukin-6
LET Linear Energy Transfer
MABG Meta-alpha-astatobenzylguanidine
MAG3 Mercaptoacetyltriglycine
mCRPC Metastatic Castration-Resistant Prostate Cancer
MDP Methylene Diphosphonate
MIBG Metaiodobenzylguanidine
MRI Magnetic Resonance Imaging
NaF Sodium Fluoride
NOTA 1,4,7-triazacyclononane-1,4,7-triacetic acid
NSCLC Non-Small Cell Lung Cancer
OPG Osteoprotegerin
PARP Poly(ADP-ribose) Polymerase
PARPi PARP Inhibitor
PET Positron Emission Tomography
PSA Prostate-Specific Antigen
PSMA Prostate-Specific Membrane Antigen
PTHrP Parathyroid Hormone-related Protein
RANK Receptor Activator of Nuclear Factor-κB
RANKL Receptor Activator of Nuclear Factor-κB Ligand
SPECT Single Photon Emission Computed Tomography
SREs Skeletal-Related Events
SUV Standardized Uptake Value
TAT Targeted Alpha Therapy
TGF-β Transforming Growth Factor-beta
TME Tumor Microenvironment
TNF-α Tumor Necrosis Factor-alpha
TRT Targeted Radionuclide Therapy
TTP Time to Progression
VEGF Vascular Endothelial Growth Factor
VEGFR Vascular Endothelial Growth Factor Receptor
WBRT Whole-Brain Radiation Therapy
WHO World Health Organization
ZOL Zoledronic Acid/Zoledronate